Collagen: Scaffold for repair or execution

Cardiovascular Research

Volumn 33, Issue 3, 1997, Pages 535-539

  Jensen, Lars Thorbjørn ^a   Høst, Nis Baun ^b  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Collagen; Extracellular matrix

Indexed keywords

COLLAGEN;

CARDIOVASCULAR DISEASE; COLLAGEN METABOLISM; EXTRACELLULAR MATRIX; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COLLAGEN; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; HUMANS; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN;

EID: 0031050835     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00247-7     Document Type: Short Survey

References (35)

1. Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA. The biosynthesis of collagen and its disorders. New Engl J Med 1979;301:1323.
2. Risteli L, Risteli J. Noninvasive methods for the detection of organ fibrosis. In: Rojkind M, ed. Connective Tissue in Health and Disease. Boca Raton, FL: CRC Press, 1990:61-98.
3. Burgeson RE. New collagens, new concepts. Annu Rev Cell Biol 1988;4:551-577.
4. Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 1989;13:1637-1652.
5. Werns SW, Lucchesi BR. Inflammation and myocardial infarction. Br Med Bull 1987;43:460-471.
6. Gay S, Miller EJ. Collagen in the Physiology and Pathology of Connective Tissue. Stuttgart, Gustav-Fischer-Verlag, 1978.
7. Hardy MA. The biology of scar formation. Phys Ther 1989;69:1014-1024.
8. Carroll EP, Janicki JS, Pick R, Weber KT. Myocardial stiffness and reparative fibrosis following coronary embolisation in the rat. Cardiovasc Res 1989;23:655-661.
9. Weber KT, Brilla CG, Cleland JGF, Cohn JN, Hansson L, Heagerty AM, Laragh JH, Laurent S, Ollivier J-P, Pauletto P, Pouleur H, Smits JFM, Tan L-B. Cardioreparation and the concept of modulating cardiovascular structure and function. Blood Pressure 1993;2:6-21.
10. Pihlajaniemi T. Kollagenfamiljen: Nya medlemmar och nya tanker om deras biosyntes. Nor Med 1995;110:96-99.
11. Fleischmajer R, Perlish JS, Timpl R. Collagen fibrillogenesis in human skin. In Fleischmajer R, Olsen BR, Kühn K, eds. Biology, Chemistry, and Pathology of Collagen. New York: New York Academy of Sciences, 1985;246-257
12. Fleischmajer R, Perlish JS. The role of the amino propeptide in collagen fibrillogenesis. Rheumatology 1986;10:91-103.
13. Laurent GJ. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol 1987;252:C1-C9.
14. Eeckhout Y, Vaes G. Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Biochem J 1977;166:21-31.
15. Cleutjens JPM, Verluyten MJA, Smits JFM, Daemen MJAP. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 1995; 147:325-338.
16. Jensen LT, Olesen HP, Risteli J, Lorenzen I. External thoracic duct-venous shunt in conscious pigs for long term studies of connective tissue metabolites in lymph. Lab Anim Sci 1990;40:620-624.
17. Jensen LT, Risteli J, Nielsen MD, Henriksen JH, Olesen HP, Risteli L, Lorenzen I. Purification of porcine aminoterminal propeptide of type III procollagen from lymph and use for lymphatic clearance studies in pigs. Matrix 1992;11:73-79.
18. Taubman MB, Goldberg B. Radioimmunoassay for human procollagen. Science 1974;186:1115-1117.
19. Brocks DG, Steinen C, Gerl M, Knolle J, Neubauer HP, Günzler V. A radioimmunoassay for the N-terminal propeptide of rat procollagen type III. Matrix 1993;13:381-387.
20. Jensen LT, Garbarsch C, Hørslev-Petersen K, Schuppan D, Kim K, Lorenzen I. Collagen metabolism during wound healing in rats. The aminoterminal propeptide of type III procollagen in serum and wound fluid in relation to formation of granulation tissue. APMIS 1993;101:557-564.
21. Jensen LT, Hørslev-Petersen K, Toft P, Bentsen KD, Grande P, Simonsen EE, Lorenzen I. Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction. Circulation 1990;81:52-57.
22. Jensen LT, Henriksen JH, Risteli J, Olesen HP, Nielsen MD, Lorenzen I. Fate of circulating amino-terminal propeptide of type III procollagen in conscious pigs. Am J Physiol 1993;265:R139-R145.
23. Jensen LT, Henriksen JH, Olesen HP, Risteli J, Lorenzen I. Lymphatic clearance of synovial fluid in conscious pigs - the aminoterminal propeptide of type III procollagen. Eur J Clin Invest 1993;23:778-784.
24. Høst NB, Jensen LT, Bendixen PM, Jensen SE, Koldkjr O, Simonsen EE. The aminoterminal propeptide of type III procollagen provides new information on prognosis following acute myocardial infarction. Am J Cardiol 1995;76:869-873.
25. Høst NB, Hansen SS, Jensen LT, Husum D, Nielsen JD. Thrombolytic therapy of acute myocardial infarction alters collagen metabolism. Cardiology 1994;85:323-333.
26. Høst NB, Stoltenberg MB, Jensen LT, Larsen OG, Aurup P. Effect on collagen metabolism of thrombolytic therapy with tissue-plasminogen activator. A randomized, placebo-controlled study. Eur J Clin Invest 1995;25:15-18.
27. Peuhkurinen KJ, Risteli L. Melkko JT, Linnaluoto M, Jounela A, Risteli J. Thrombolytic therapy with streptokinase stimulates collagen breakdown. Circulation 1991;83:1969-1975.
28. Peuhkurinen K, Risteli L, Jounela A, Risteli J. Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator. Am Heart J 1996;131:7-13.
29. Honan MB, Harrel FE, Reimer KA, Califf RM, Mark DB, Pryor DB, Hlatky MA. Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol 1990;16:359-367.
30. Andersen HV, Willerson JT. Thrombolysis in acute myocardial infarction. New Engl J Med 1993;329:703-709.
31. Bonnet J, Garderes PE, Aumailley M, Moreau C, Gouverneur G, Benchimol D, Crockett R, Larrue J, Bricaud H. Serum type III procollagen peptide levels in coronary artery disease (a marker of atherosclerosis). Eur J Clin Invest 1988;18:18-21.
32. Diéz J, Laviades C, Mayor G, Gil MJ, Monreal I. Increased serum concentrations of procollagen peptides in essential hypertension. Circulation 1995;91:1450-1456.
33. Klappacher G, Franzen P, Haab D, Mehrabi M, Binder M, Plesch K, Pacher R, Grimm M, Pribil I, Eichler H-G, Glogar D. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischémie dilated cardiomyopathy and mpact on diagnosis and prognosis. Am J Cardiol 1995;75:913-918.
34. Høst NB, Aldershvile J, Jensen LT, Mortensen S-A, Pettersson G, Høyer S, Haunsø S. Aminoterminal propeptide of type III procollagen reflects formation of collagen following rejection after heart transplantation. Transpl Proc 1994;26:1813.
35. Oikarinen A, Autio P, Vuori J, Vaananen K, Risteli L, Kiistala U, Risteli J. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen. Br J Dermatol 1992;126:172-178.